All lobbying filings
THE KPM GROUP DC LLC
Lobbying for SOLENO THERAPEUTICS, INC. · Soleno is focused on development of novel therapeutics for treatment of rare diseases.
Filing · LD-2 quarterly report
Q3 termination
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
California
Representation ended
Sep 30, 2026
The registrant reported terminating its work for this client.
Government bodies contacted
2
Lobbying activity
1
HR 5509/S.2903 Safe Step Act HR 6423/S. 864 HELP Copays Act